Skip to main content

Lilly 3977 40 mg (Retevmo 40 mg)

Generic Name: selpercatinib

Pill with imprint Lilly 3977 40 mg is Gray, Capsule-shape and has been identified as Retevmo 40 mg. It is supplied by Eli Lilly and Company.

Retevmo is used in the treatment of non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. Retevmo 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lilly 3977 40 mg

Retevmo 40 mg Lilly 3977 40 mg

Retevmo

Generic Name
selpercatinib
Imprint
Lilly 3977 40 mg
Strength
40 mg
Color
Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Eli Lilly and Company
National Drug Code (NDC)
00002-3977

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.